Market Overview:
The global recombinant human proteins market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for recombinant human proteins from laboratories and medical applications. The protein production segment is expected to dominate the global recombinant human proteins market during the forecast period, owing to the growing demand for recombinant human proteins for research and development purposes. The protein purification segment is also expected to witness significant growth during the forecast period, due to rising demand for purified recombinant human proteins from pharmaceutical and biotechnology companies. North America dominates the global recombinant human proteins market, followed by Europe and Asia Pacific.
Product Definition:
A recombinant human protein is a protein that is produced by genetically engineering cells to produce the desired protein. These proteins can be used for a variety of purposes, including research, diagnostics, and therapeutics. Recombinant human proteins are important because they can be used to study diseases and develop new treatments.
Protein Production:
Protein production is the process of making a protein. Proteins are made up of amino acids. The body cannot make some essential amino acids, such as histidine, lysine and methionine; hence these have to be supplied by diet or supplements. Some proteins can also be made in the body but this depends on factors like age and other medical conditions (like cancer).
Protein Purification:
Protein purification is the process to remove unwanted substances from protein or peptide products. Protein purification can be done by various methods which include gel filtration, ion exchange, affinity, and reverse-phase chromatography. Affinity tag method is one of the widely used methods for protein purification which involves the binding of an antibody or other ligand to a desired protein followed by its isolation.
Application Insights:
The application segment is segregated into two parts, namely laboratories and medical applications. The laboratories segment dominated the global market in terms of revenue share in 2017. This can be attributed to the rising number of R&D activities being carried out with recombinant proteins as a major focus. In addition, an increase in government funding for research related to protein production has also positively influenced the growth of this application segment over the forecast period.
Medical applications are anticipated to witness significant growth during the forecast period owing to increasing incidences of chronic diseases such as cancer and diabetes mellitus which require a high demand for protein-based therapeutics for treatment purposes. Moreover, there is also an increased need for advanced diagnostics techniques that provide rapid results while handling sensitive samples thereby driving this market at a lucrative rate during the estimated time frame.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The presence of a large number of biopharmaceutical companies and research institutes involved in R&D activities using recombinant human proteins is one of the major factors contributing to this market growth. Moreover, increasing investments by governments for development of advanced healthcare technologies are also expected to drive regional demand over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising awareness among people regarding availability and benefits associated with these products, coupled with growing medical tourism industry in countries such as Japan, China, India and Australia. In addition, increasing investment by governments on improving healthcare infrastructure is also expected favorably impact overall market development during the estimated time span.
Growth Factors:
- Increasing demand for recombinant human proteins in the biopharmaceutical and research industries due to their therapeutic potential.
- Growing prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases that require regular protein therapy for treatment.
- Rising number of clinical trials being conducted for recombinant human proteins therapies to obtain regulatory approvals.
- Technological advancements in recombinant human protein production that are making them more affordable and accessible to a wider range of users.
Scope Of The Report
Report Attributes
Report Details
Report Title
Recombinant Human Proteins Market Research Report
By Type
Protein Production, Protein Purification
By Application
Laboratories, Medical
By Companies
Santa Cruz Biotechnology, OriGene, Cusabio, Amsbio, RayBiotech, Enzyme Research Laboratories, HYPHEN BIOMED, Santa Cruz Biotechnology
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
209
Number of Tables & Figures
147
Customization Available
Yes, the report can be customized as per your need.
Global Recombinant Human Proteins Market Report Segments:
The global Recombinant Human Proteins market is segmented on the basis of:
Types
Protein Production, Protein Purification
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Laboratories, Medical
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Santa Cruz Biotechnology
- OriGene
- Cusabio
- Amsbio
- RayBiotech
- Enzyme Research Laboratories
- HYPHEN BIOMED
- Santa Cruz Biotechnology
Highlights of The Recombinant Human Proteins Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Protein Production
- Protein Purification
- By Application:
- Laboratories
- Medical
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Recombinant Human Proteins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Recombinant human proteins are proteins that have been created by recombining the genetic material of two different organisms. This process is often used to create new proteins that have properties that are not found in either of the original sources.
Some of the major companies in the recombinant human proteins market are Santa Cruz Biotechnology, OriGene, Cusabio, Amsbio, RayBiotech, Enzyme Research Laboratories, HYPHEN BIOMED, Santa Cruz Biotechnology.
The recombinant human proteins market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Recombinant Human Proteins Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Recombinant Human Proteins Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Recombinant Human Proteins Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Recombinant Human Proteins Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Recombinant Human Proteins Market Size & Forecast, 2020-2028
4.5.1 Recombinant Human Proteins Market Size and Y-o-Y Growth
4.5.2 Recombinant Human Proteins Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Protein Production
5.2.2 Protein Purification
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Laboratories
6.2.2 Medical
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Recombinant Human Proteins Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Recombinant Human Proteins Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Protein Production
9.6.2 Protein Purification
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Laboratories
9.10.2 Medical
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Protein Production
10.6.2 Protein Purification
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Laboratories
10.10.2 Medical
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Protein Production
11.6.2 Protein Purification
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Laboratories
11.10.2 Medical
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Protein Production
12.6.2 Protein Purification
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Laboratories
12.10.2 Medical
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Protein Production
13.6.2 Protein Purification
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Laboratories
13.10.2 Medical
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Recombinant Human Proteins Market: Competitive Dashboard
14.2 Global Recombinant Human Proteins Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Santa Cruz Biotechnology
14.3.2 OriGene
14.3.3 Cusabio
14.3.4 Amsbio
14.3.5 RayBiotech
14.3.6 Enzyme Research Laboratories
14.3.7 HYPHEN BIOMED
14.3.8 Santa Cruz Biotechnology
